Anthrax Treatment Market - Top Companies and Manufacturers

  • Report ID: 5771
  • Published Date: Oct 22, 2024
  • Report Format: PDF, PPT

Companies Dominating the Anthrax Treatment Market

    • Pfizer Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Integrated Bio Therapeutics Inc.
    • Sun Pharmaceutical Industries Ltd.
    • Bayer AG
    • Zydus Group
    • GC Biopharma, corp.
    • BlueWillow Biologics.
    • Emergent BioSolutions
    • ARISTO Pharmaceuticals Private Limited

Browse Key Market Insights with Data Illustration:

In the News

  • Emergent BioSolutions received approval from the US Food and Drug Administration (FDA) for, Cyfendus an adjuvant-packed adsorbed version of the anthrax vaccination approved for usage in post-exposure prophylaxis in adults between the ages of 18 and 65.
  • GC Biopharma, corp. applied to obtain approval from the Korean Ministry of Food and Drug Safety (MFDS) for, "GC1109", an anthrax vaccine developed by GC Biopharma and the Korea Disease Control and Prevention Agency (KDCA), that contains protective antigen (PA), and will be the first recombinant anthrax vaccine in history if it is authorized to aid in the preparation for a possible bioterrorism attack and the ensuing national emergency.

Author Credits:  Radhika Pawar


  • Report ID: 5771
  • Published Date: Oct 22, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of anthrax treatment is assessed at USD 443.3 million.

Anthrax Treatment Market size was over USD 417.26 million in 2024 and is expected to reach USD 1.1 billion by the end of 2037, witnessing around 7.8% CAGR during the forecast period i.e., between 2025-2037. The growing population of animals across the globe and the growing awareness will drive the market growth.

North America industry is anticipated to account for largest revenue share of 35% by 2037, impelled by rising spending in healthcare in the region.

The major players in the market are Integrated Bio Therapeutics Inc., Sun Pharmaceutical Industries Ltd., Bayer AG, Zydus Group, GC Biopharma, corp., BlueWillow Biologics., ARISTO Pharmaceuticals Private Limited, Takeda Pharmaceutical Company Limited, and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample